2 Clinical Trials for Various Conditions
The primary objective is to compare the efficacy of silodosin 4 and 8 mg once daily with placebo in the treatment of subjects with moderate to severe abacterial chronic prostatitis/chronic pelvic pain syndrome during a 12 week treatment period. The secondary objective is to compare the safety of silodosin 4 and 8 mg once daily with placebo.
The purpose of this study is to determine whether tanezumab is effective in the treatment of pain associated with chronic prostatitis.